Researchers discover first treatment to improve survival in rare heart condition
Tafamidis is the first treatment to improve survival and reduce hospitalisations in a rare heart condition called transthyretin amyloid cardiomyopathy, according to late breaking research presented today in a Hot Line Session ...
Aug 27, 2018
0
0